On Wednesday, April 3, the Senate Finance Committee will hold its third hearing on drug-pricing this year, and five of the leading PBMs will be called to testify.

On April 3rd, pharmacy benefit managers (PBMs), the invisible middlemen of the health care industry, will be front and center for the world to see. No longer able to lurk behind the scenes, top executives from five PBMs—UnitedHealth Group’s Optum, Cigna Corp, Humana Inc, CVS Health Corp, CVS Caremark, and Prime Therapeutics LLC—have been invited to testify before Congress as part of a series of drug pricing hearings examining the healthcare marketplace and soaring drug costs.

PBMs were initially set up to help control drug utilization and cost. It was thought that having middlemen specifically devoted to increasing efficiency and lowering cost that they could improve the system for everyone involved.

Complete your profile to continue reading and get FREE access to BenefitsPRO.com, part of your ALM digital membership.

Your access to unlimited BenefitsPRO.com content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical BenefitsPRO.com information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com

Already have an account?



Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.